Ani Pharmaceuticals (ANIP) Shares Outstanding (2016 - 2022)
Historic Shares Outstanding for Ani Pharmaceuticals (ANIP) over the last 12 years, with Q2 2022 value amounting to $17.6 million.
- Ani Pharmaceuticals' Shares Outstanding rose 3695.62% to $17.6 million in Q2 2022 from the same period last year, while for Jun 2022 it was $17.6 million, marking a year-over-year increase of 3695.62%. This contributed to the annual value of $16.9 million for FY2021, which is 3606.6% up from last year.
- Latest data reveals that Ani Pharmaceuticals reported Shares Outstanding of $17.6 million as of Q2 2022, which was up 3695.62% from $17.4 million recorded in Q1 2022.
- Ani Pharmaceuticals' Shares Outstanding's 5-year high stood at $17.6 million during Q2 2022, with a 5-year trough of $11730.0 in Q1 2018.
- Over the past 5 years, Ani Pharmaceuticals' median Shares Outstanding value was $12.2 million (recorded in 2020), while the average stood at $11.1 million.
- Its Shares Outstanding has fluctuated over the past 5 years, first surged by 10240639.39% in 2019, then soared by 73.19% in 2020.
- Over the past 5 years, Ani Pharmaceuticals' Shares Outstanding (Quarter) stood at $11.9 million in 2018, then rose by 2.04% to $12.1 million in 2019, then rose by 2.68% to $12.4 million in 2020, then skyrocketed by 36.07% to $16.9 million in 2021, then rose by 3.86% to $17.6 million in 2022.
- Its last three reported values are $17.6 million in Q2 2022, $17.4 million for Q1 2022, and $16.9 million during Q4 2021.